Skip to main content Accessibility help
×
Home
Hostname: page-component-79b67bcb76-6tv95 Total loading time: 0.221 Render date: 2021-05-16T09:41:56.870Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": false, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true }

Cannabis use and genetic predisposition for schizophrenia: a case-control study

Published online by Cambridge University Press:  19 May 2008

W. Veling
Affiliation:
Parnassia Psychiatric Institute, The Hague, The Netherlands Erasmus Medical Center, Department of Public Health, Rotterdam, The Netherlands
J. P. Mackenbach
Affiliation:
Erasmus Medical Center, Department of Public Health, Rotterdam, The Netherlands
J. van Os
Affiliation:
European Graduate School of Neuroscience and South Limburg Mental Health Research and Teaching Network, Maastricht University, Maastricht, The Netherlands Division of Psychological Medicine, Institute of Psychiatry, London, UK
H. W. Hoek
Affiliation:
Parnassia Psychiatric Institute, The Hague, The Netherlands Columbia University, Department of Epidemiology, New York, NY, USA University Medical Center Groningen, Department of Psychiatry, Groningen, The Netherlands
Corresponding
E-mail address:

Abstract

Background

Cannabis use may be a risk factor for schizophrenia. Part of this association may be explained by genotype–environment interaction, and part of it by genotype–environment correlation. The latter issue has not been explored. We investigated whether cannabis use is associated with schizophrenia, and whether gene–environment correlation contributes to this association, by examining the prevalence of cannabis use in groups with different levels of genetic predisposition for schizophrenia.

Method

Case-control study of first-episode schizophrenia. Cases included all non-Western immigrants who made first contact with a physician for schizophrenia in The Hague, The Netherlands, between October 2000 and July 2005 (n=100; highest genetic predisposition). Two matched control groups were recruited, one among siblings of the cases (n=63; intermediate genetic predisposition) and one among immigrants who made contact with non-psychiatric secondary health-care services (n=100; lowest genetic predisposition). Conditional logistic regression analyses were used to predict schizophrenia as a function of cannabis use, and cannabis use as a function of genetic predisposition for schizophrenia.

Results

Cases had used cannabis significantly more often than their siblings and general hospital controls (59, 21 and 21% respectively). Cannabis use predicted schizophrenia [adjusted odds ratio (OR) cases compared to general hospital controls 7.8, 95% confidence interval (CI) 2.7–22.6; adjusted OR cases compared to siblings 15.9 (95% CI 1.5–167.1)], but genetic predisposition for schizophrenia did not predict cannabis use [adjusted OR intermediate predisposition compared to lowest predisposition 1.2 (95% CI 0.4–3.8)].

Conclusions

Cannabis use was associated with schizophrenia but there was no evidence for genotype–environment correlation.

Type
Original Articles
Copyright
Copyright © 2008 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below.

References

Andreasen, NC, Flaum, M, Arndt, S (1992). The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Archives of General Psychiatry 49, 615623.CrossRefGoogle ScholarPubMed
Arseneault, L, Cannon, M, Witton, J, Murray, RM (2004). Causal association between cannabis and psychosis: examination of the evidence. British Journal of Psychiatry 184, 110117.CrossRefGoogle Scholar
Caspi, A, Moffitt, TE, Cannon, M, McClay, J, Murray, R, Harrington, H, Taylor, A, Arseneault, L, Williams, B, Braithwaite, A, Poulton, R, Craig, IW (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene×environment interaction. Biological Psychiatry 57, 11171127.CrossRefGoogle Scholar
Collip, D, Myin-Germeys, I, Van Os, J (2008). Does the concept of ‘sensitization’ provide a plausible mechanism for the putative link between the environment and schizophrenia? Schizophrenia Bulletin 34, 220225.CrossRefGoogle Scholar
Eaves, L, Chen, S, Neale, M, Maes, HH, Silberg, J (2005). Questions, models, and methods in psychiatric genetetics. In Psychiatric Genetics (ed. Kendler, K. S. and Eaves, L.), pp. 1994. American Psychiatric Publishing: Washington, DC.Google Scholar
Ferdinand, RF, Sondeijker, F, Van der Ende, J, Selten, JP, Huizink, A, Verhulst, FC (2005). Cannabis use predicts future psychotic symptoms, and vice versa. Addiction 100, 612618.CrossRefGoogle ScholarPubMed
Henquet, C, Krabbendam, L, Spauwen, J, Kaplan, C, Lieb, R, Wittchen, HU, van Os, J (2005 a). Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. British Medical Journal 330, 1114.CrossRefGoogle ScholarPubMed
Henquet, C, Murray, R, Linszen, D, Van Os, J (2005 b). The environment and schizophrenia: the role of cannabis use. Schizophrenia Bulletin 31, 608612.CrossRefGoogle ScholarPubMed
Henquet, C, Rosa, A, Krabbendam, L, Papiol, S, Fananas, L, Drukker, M, Ramaekers, JG, van Os, J (2006). An experimental study of catechol-O-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology 31, 27482757.CrossRefGoogle ScholarPubMed
MacLeod, J (2007). Cannabis use and symptom experience amongst people with mental illness: a commentary on Degenhardt et al. Psychological Medicine 37, 913916.CrossRefGoogle ScholarPubMed
Moore, THM, Zammit, S, Lingford-Hughes, A, Barnes, TRE, Jones, PB, Burke, M, Lewis, G (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370, 319328.CrossRefGoogle ScholarPubMed
Murray, RM, Jones, PB, Susser, E, Van Os, J, Cannon, M (eds) (2003). The Epidemiology of Schizophrenia. Cambridge University Press: Cambridge.Google Scholar
Smitten, MH, Smeets, RMW, Van den Brink, W (1998). Composite International Diagnostic Interview (CIDI), Version 2.1. World Health Organization: Amsterdam.Google Scholar
Stefanis, NC, Delespaul, P, Henquet, C, Bakoula, C, Stefanis, CN, van Os, J (2004). Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 99, 13331341.CrossRefGoogle Scholar
Veling, W, Selten, JP, Veen, N, Laan, W, Blom, JD, Hoek, HW (2006). Incidence of schizophrenia among ethnic minorities in the Netherlands: a four-year first-contact study. Schizophrenia Research 86, 189193.CrossRefGoogle ScholarPubMed
Verdoux, H, Gindre, C, Sorbara, F, Tournier, M, Swendsen, JD (2003). Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study. Psychological Medicine 33, 2332.CrossRefGoogle ScholarPubMed

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Cannabis use and genetic predisposition for schizophrenia: a case-control study
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Cannabis use and genetic predisposition for schizophrenia: a case-control study
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Cannabis use and genetic predisposition for schizophrenia: a case-control study
Available formats
×
×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *